国际皮肤性病学杂志    2002 28 (6): 356-359   ISSN: 2096-5540  CN: 32-1880/R  

过氧化氢与白癜风的发病机制
张汝芝, 朱文元
南京医科大学第一附属医院皮肤科, 210029
收稿日期 2002-01-23  修回日期 null  网络版发布日期 null
参考文献  [1] Jimenez-Cervantes C, Martinez-Esparza M, Perez C, et al. Inhibition of melanogenesis in response to oxidative stress:transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J Cell Sci, 2001, 114 (Pt 12):2335-2344.
[2] Schallreuter KU, Moore J, Wood JM, et al. Epidermal H (2) O (2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo:identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol, 2001, 116 (1):167-174.
[3] Schallreuter KU, Wood JM, Pittelkow MR, et al. Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Arch Dermatol Res, 1996, 288(1):14-18.
[4] Schallreuter KU. A review of recent advances on the regulation of pigmentation in the human epidermis. Cell Mol Biol (Noisy-legrand), 1999, 45(7):943-949.
[5] Schallreuter KU, Wood JM, Pittelkow MR, et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science, 1994, 263(5152):1444-1446.
[6] Schallreuter KU, Buttner G, Pittelkow MR, et al. Cytotoxicity of 6-biopterin to human melanocytes. Biochem Biophys Res Commun,1994, 204(1):43-48.
[7] Kalko SG, Gelpi JL, Fita I, et al. Theoretical study of the mechanisms of substrate recognition by catalase. J Am Chem Soc, 2001, 123(39):9665-9672.
[8] Schallreuter KU, Wood JM, Berger J. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol, 1991,97(6):1081-1085.
[9] Beazley WD, Gaze D, Panske A, et al. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol,1999, 141(2):301-303.
[10] Maresca V, Roccella M, Roccella F, et al. Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol, 1997, 109(3):310-313.
[11] Tobin DJ, Swanson NN, Pittelkow MR, et al. Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol, 2000, 191(4):407-416.
[12] Bartosik J, Wulf HC, Kobayasi T. Melanin and melanosome complexes in long standing stable vitiligo--an ultrastructural study. Eur J Dermatol, 1998, 8(2):95-97.
[13] Yohn JJ, Norris DA, Yrastorza DG, et al. Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes,and melanocytes. J Invest Dermatol, 1991, 97 (3):405-409.
[14] Haycock JW, Rowe SJ, Cartledge S, et al. Alpha-melanocytestimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem, 2000, 275(21):15629-15636.
[15] Passi S, Grandinetti M, Maggio F, et al. Epidermal oxidative stress in vitiligo. Pigment Cell Res, 1998, 11 (2):81-85.
[16] Schallreuter KU, Wood JM, Lemke KR, et al. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure:a case study on 33 patients. Dermatology, 1995, 190 (3):223-229.
[17] Schallreuter KU. Successful treatment of oxidative stress in vitiligo.Skin Pharmacol Appl Skin Physiol, 1999, 12 (3):132-138.
[18] Schallreuter KU, Moore J, Wood JM, et al. In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc, 1999, 4 (1):91-96.

通讯作者: